CaliberCos

CWD · NASDAQ

$0.434+$0.0095 (+2.24%)TodayMarket closed ·
Prev close $0.4245

About CWD

CaliberCos, Inc. operates as an asset management firm. The company is headquartered in Scottsdale, Arizona and currently employs 50 full-time employees. The company went IPO on 2023-05-17. The firm is engaged in building wealth for its clients by creating, managing, and servicing middle-market investment funds, private syndications, and direct investments. Through its funds, the Company invests primarily in real estate, private equity, and debt facilities. The firm markets and fundraises to direct channels and to wholesale channels. Its asset management activities are complemented with transaction and advisory services, including development and construction management, acquisition and disposition expertise, and fund formation. The firm provides various support services to the investments it manages, including asset management services, fund set-up services, lending support, construction and development management, and real estate brokerage.

Employees
50
Headquarters
Scottsdale, Arizona
Listed
May 17, 2023
Sector
Financials
Industry
Capital Markets

CWD key statistics

Market cap
4.41M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
5.54M
Volume
69.23K
Open price
$0.424
High today
$0.434
Low today
$0.4046
52 Week high
$4.09
52 Week low
$0.4012

CaliberCos (CWD) at a glance

As of Oct 20, 2026, CaliberCos (CWD) shares are priced at $0.434, giving the company a market cap of 4.41M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.4046 and $0.434. The current price is 7.3% above the day's low and 0.0% below its high.

Volume so far is 69.23K shares, below the average of 5.54M shares a day.

Over the past year CaliberCos has ranged from $0.4012 to $4.09, and now sits 1% of the way up that range.

CaliberCos met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY26 it reported -$0.39 per share against an estimate of -$0.1818.

CWD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 107.6% on average.

  1. Q3 FY24: reported $0.20 per share against an estimate of -$2.63
  2. Q4 FY24: reported -$10.20 per share against an estimate of -$0.808
  3. Q4 FY25: reported -$1.24 per share against an estimate of -$0.3939
  4. Q1 FY25: reported -$3.85 per share against an estimate of -$0.404
  5. Q2 FY25: reported -$4.15 per share against an estimate of -$0.9494
  6. Q3 FY25: reported -$1.39 per share against an estimate of -$0.3232
  7. Q1 FY26: reported -$0.62 per share against an estimate of -$0.2525
  8. Q2 FY26: reported -$0.39 per share against an estimate of -$0.1818

CWD news

  • Press releaseGlobe Newswire

    Caliber Sets Date for Second Quarter 2026 Earnings Announcement & Investor Conference Call

  • Akanksha Bakshi

    Calibercos Stock Slides as Chainlink Rally Quickly Loses Steam

  • Avi Kapoor

    US Stocks Higher; Nasdaq Gains Over 150 Points

  • Mohd Haider

    CaliberCos (CWD) Stock Is Trending Overnight — Here's Why it Fell Over 25% in After-Hours Session

  • Avi Kapoor

    Crude Oil Down Over 1%; US Initial Jobless Claims Fall

  • Avi Kapoor

    Dow Gains Over 250 Points; US Jobs Rise By 57,000 In June

  • Press releaseGlobe Newswire

    Caliber Sets Date for First Quarter 2026 Earnings Announcement & Investor Conference Call

  • Press releaseGlobe Newswire

    Caliber Sets Date for Fourth Quarter 2025 Earnings Announcement & Investor Conference Call

Similar companies

Companies in the same industry as CaliberCos

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.